Lotus Health Group Company Stock price

Equities

600186

CNE000000WY0

Food Processing

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
4.77 CNY +4.15% Intraday chart for Lotus Health Group Company -7.56% -21.16%
Sales 2021 1.81B 251M Sales 2022 1.69B 234M Capitalization 4.82B 668M
Net income 2021 44M 6.09M Net income 2022 46M 6.37M EV / Sales 2021 2.32 x
Net cash position 2021 1.19B 165M Net cash position 2022 1.35B 186M EV / Sales 2022 2.06 x
P/E ratio 2021
100 x
P/E ratio 2022
90.3 x
Employees 1,413
Yield 2021 *
-
Yield 2022
-
Free-Float 62.05%
More Fundamentals * Assessed data
Dynamic Chart
Lotus Health to Buy 50% of Malaysian MSG Producer MT
Lotus Health Group Company entered into letter of intent to acquire 50% stake in Ajinoriki Msg Sdn. Bhd. from Loo Siew Kim and Kee Seok Chean. CI
Court Orders Lotus Health to Pay 37 Million Yuan in Overdue Loans to China Development Bank; Shares Down 4% MT
Lotus Health Faces Reconsideration Hearing for Nearly 102 Million Yuan Loan Dispute MT
Shanghai Bourse Questions Lotus Health Fund Sources for 693 Million Yuan Technology Contract MT
Lotus Health to Buy 330 Nvidia Servers For 693 Million Yuan MT
Lotus Health Group Company Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tranche Update on Lotus Health Group Company's Equity Buyback Plan announced on May 25, 2022. CI
Lotus Health Group Company's Equity Buyback announced on May 25, 2022 has expired with 19,381,400 shares, representing 1.08% for CNY 50 million. CI
Lotus Health Group Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on Lotus Health Group Company's Equity Buyback Plan announced on May 25, 2022. CI
Lotus Health Group Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tranche Update on Lotus Health Group Company's Equity Buyback Plan announced on May 25, 2022. CI
Lotus Health Group Company Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on Lotus Health Group Company's Equity Buyback Plan announced on May 25, 2022. CI
More news
1 day+4.15%
1 week-7.56%
Current month+3.25%
1 month-3.25%
3 months-16.75%
6 months-12.32%
Current year-21.16%
More quotes
1 week
4.53
Extreme 4.53
5.24
1 month
4.30
Extreme 4.3
5.37
Current year
3.29
Extreme 3.29
6.50
1 year
2.58
Extreme 2.58
8.24
3 years
1.96
Extreme 1.96
8.24
5 years
0.94
Extreme 0.9389
8.24
10 years
0.94
Extreme 0.9389
8.24
More quotes
Managers TitleAgeSince
President 52 22-08-09
President 40 20-05-31
Chairman 46 21-04-19
Members of the board TitleAgeSince
Director/Board Member 68 20-02-18
Director/Board Member 53 22-08-28
Director/Board Member 55 22-08-25
More insiders
Date Price Change Volume
24-03-27 4.77 +4.15% 94 722 800
24-03-27 4.58 -8.22% 126,273,200
24-03-26 4.99 -1.96% 104,397,400
24-03-25 5.09 -0.39% 125,746,200
24-03-22 5.11 +0.99% 114,227,100

End-of-day quote Shanghai S.E., March 27, 2024

More quotes
Lotus Health Group Company, formerly Lotus Health Industry Holding Group Company, is a China-based company primarily engaged in the production and distribution of monosodium glutamate and other flavoring products. The Company's principal products are monosodium glutamate under the brand named Lotus Flower. The Company also offers chicken essence, soy sauce, vinegar, sodium glutamate, glutamic acid, amylaceum, cube sugar, flour, gluten powder, starch, vegetarian products, as well as feed and fertilizer, among others. The Company distributes its products in domestic and overseas markets.
More about the company
  1. Stock
  2. Equities
  3. Stock Lotus Health Group Company - Shanghai S.E.